ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 670,74
1,16%
DAX
18 001,60
0,54%
Brent Oil
83,135
-0,59%
Bitcoin
61 814,67
4,56%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. 2seventy bio Inc (TSVT)

  7. 2seventy bio Inc (TSVT) Actualités

TSVT 2seventy bio Inc

4,7499
-0,1801 (-3,65%)
Dernière mise à jour : 17:46:43
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
2seventy bio Inc TSVT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,1801 -3,65% 4,7499 17:46:43
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,93 4,71 5,1299 4,93
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202413:00BW2seventy bio to Report First Quarter 2024 Financial Results..
05/4/202415:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
01/4/202413:30BW2seventy bio Announces Completion of Oncology and Autoimmune..
20/3/202422:04BW2seventy bio Announces Appointments of Eli Casdin and..
15/3/202423:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
07/3/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202413:03EDGAR2Form 8-K - Current report
05/3/202413:00BW2seventy bio Reports Fourth Quarter and Full Year 2023..
01/3/202413:00BW2seventy bio to Report Fourth Quarter and Full Year 2023..
05/2/202422:05BW2seventy bio to Participate in Upcoming Investor Conferences
05/2/202413:02EDGAR2Form 8-K - Current report
05/2/202412:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02/2/202422:54EDGAR2Form 8-K/A - Current report: [Amend]
30/1/202415:25APSBiotech Shares Soar Premarket On Sale Of R&D Assets
30/1/202413:48EDGAR2Form 8-K - Current report
30/1/202413:01BW2seventy bio Announces New Strategic Path Forward
05/1/202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/12/202313:25EDGAR2Form 8-K - Current report
12/12/202301:30BWAbecma Delivers Sustained Progression-Free Survival Versus..
11/12/202313:00BW2seventy bio to Host Investor Call at 8:00am ET on Tuesday,..
06/12/202320:00BW2seventy bio Reiterates Commitment to Maximizing Shareholder..
01/12/202312:49EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202312:46EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202312:43EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202312:40EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20/11/202320:31DJNTrending: Bristol Myers Squibb's Blood Cancer Treatment..
20/11/202314:30DJN2seventy Bio Shares Fall Premarket on Abecma Expansion Delay
20/11/202313:56DJNFDA Advisory Panel to Meet on Earlier Use of Abecma From..
20/11/202313:20EDGAR2Form 8-K - Current report
20/11/202312:59BWBristol Myers Squibb and 2seventy bio Provide Update on U.S...
14/11/202313:00BW2seventy bio Reports Third Quarter Financial Results and..
10/11/202313:00BW2seventy bio to Report Third Quarter 2023 Financial Results..
26/10/202313:05EDGAR2Form 8-K - Current report
13/9/202322:03EDGAR2Form 8-K - Current report
12/9/202313:13EDGAR2Form 8-K - Current report
12/9/202313:00BW2seventy bio Announces Strategic Restructuring to Prioritize..
12/9/202312:55BW2seventy bio and JW Therapeutics Announce Intent To Expand..
06/9/202322:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/9/202313:00BW2seventy bio to Participate in the 2023 Morgan Stanley..
17/8/202301:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/8/202302:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:02EDGAR2Form 8-K - Current report
14/8/202313:00BW2seventy bio Reports Second Quarter Financial Results and..
08/8/202313:00BW2seventy bio to Report Second Quarter 2023 Financial Results..
01/8/202322:15BW2seventy bio to Participate in 2023 Wedbush PacGrow..
27/7/202315:16EDGAR2Form 8-K - Current report
14/6/202313:00BW2seventy bio Announces Clinical Study Pause of PLAT-08 Trial..
07/6/202313:00BW2seventy bio to Participate in Upcoming Investor Conference

Dernières Valeurs Consultées

NASDAQ
TSVT
2seventy bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés